Cover Image

Influence of MP 29-02 on ciliary beat frequency in human epithelial cells in vitro

MP 29-02, which contains fluticasone propionate and azelastine hydrochloride, is used as a topical nasal application for the treatment of seasonal and perennial allergic rhinitis. Although a multitude of data is available on the clinical symptom reduction and treatment safety of MP 29-02, the effect...

Full description

Saved in:
Bibliographic Details
Main Authors: Häussler, Daniel (Author) , Sommer, Ulrich (Author) , Nastev, Alexander (Author) , Aderhold, Marc Christoph (Author) , Schell, Angela (Author) , Kramer, Benedikt (Author) , Stuck, Boris (Author)
Other Authors: Birk, Richard (Other)
Format: Article (Journal)
Language:English
Published: 19 April 2018
In: European archives of oto-rhino-laryngology and head & neck
Year: 2018, Volume: 275, Issue: 6, Pages: 1483-1490
ISSN:1434-4726
DOI:10.1007/s00405-018-4979-3
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00405-018-4979-3
Get full text
Author Notes:D. Häussler, J.U. Sommer, A. Nastev, C. Aderhold, A. Wenzel, B. Kramer, B.A. Stuck and R. Birk
Description
Summary:MP 29-02, which contains fluticasone propionate and azelastine hydrochloride, is used as a topical nasal application for the treatment of seasonal and perennial allergic rhinitis. Although a multitude of data is available on the clinical symptom reduction and treatment safety of MP 29-02, the effect of MP 29-02 on ciliary beat frequency (CBF) has not been evaluated thus far.
Item Description:Gesehen am 20.04.2020
Physical Description:Online Resource
ISSN:1434-4726
DOI:10.1007/s00405-018-4979-3

Similar Items